Back to Search
BRUCE CHESON, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1992703862Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
21035(DC)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
D0035917(MD)
Research & Publications (20)
Hematologic malignancies: new developments and future treatments.
PMID 12170431·Semin Oncol·2002
6-review
Rituximab: clinical development and future directions.
PMID 11772344·Expert Opin Biol Ther·2002
6-review
Emerging therapies and future directions in chronic lymphocytic leukaemia--chemotherapy.
PMID 11036950·Hematol Cell Ther·2000
6-review
Novel therapeutic agents for the treatment of myelodysplastic syndromes.
PMID 11049023·Semin Oncol·2000
6-review
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
PMID 11090046·Blood·2000
6-review
Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
PMID 19521331·Clin Adv Hematol Oncol·2009
6-review
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.
PMID 18931344·Blood·2009
3-trial
The new and ever changing PhRMA guidelines are impeding productive relationship.
PMID 19645132·Clin Adv Hematol Oncol·2009
8-other
Novel therapies for peripheral T-cell non-Hodgkin's lymphomas.
PMID 19367159·Curr Opin Hematol·2009
6-review
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691.
PMID 19626540·Leuk Lymphoma·2009
3-trial
Adult Burkitt lymphoma: too soon to declare victory.
PMID 19227573·Oncology (Williston Park)·2008
8-other
A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies.
PMID 19088047·Clin Cancer Res·2008
3-trial
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
PMID 19021050·Leuk Lymphoma·2008
3-trial
Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
PMID 18998258·Clin Adv Hematol Oncol·2008
8-other
Staging and evaluation of the patient with lymphoma.
PMID 18954739·Hematol Oncol Clin North Am·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6410 ROCKLEDGE DR, SUITE 660
BETHESDA, MD 20817 - Phone
- (301) 571-0019
Quick Facts
- NPI
- 1992703862
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile